Table A1.
Constraints | |||
---|---|---|---|
Priority | Volume | Dose metric | Limit (Gy) |
PTV | Dmax | 61.5 | |
UrethraPlan | D5% | 45 | |
D10% | 42 | ||
Dmean | 40 | ||
Rectum | Dmax | 38 | |
D1cc | 32.3 | ||
Rectum mucosa | Dmax | 27 | |
Bladder | Dmax | 41.8 | |
D1cc | 38 | ||
Penile bulb | Dmax | 1.5 | |
Ring PTV 2–3cm | Dmax | 25 | |
Skin dose | Dmax | 20 | |
Shell 3 mm | Dmax | 38 | |
Shell 3 cm | Dmax | 20 | |
Shell 5 cm | Dmax | 20 |
Objectives | |||||
---|---|---|---|---|---|
Priority | Volume | Dose metric | Goal | Sufficient | Parameters |
1 | PTV ‐ OARs | LTCP | 0.01 | 0.01 | = 37 Gy, = 0.90 |
2 | PTV | LTCP | 0.25 | 0.25 | = 37 Gy, = 0.60 |
3 | UrethraPlan | Dmean | 39 Gy | 38 Gy | |
4 | LTCP | 0.50 | = 40 Gy, = −0.50 | ||
5 | Rectum | LTCP | 0.00 | = 27 Gy, = −0.20 | |
6 | Bladder | LTCP | 0.00 | = 31 Gy, = −0.20 | |
7 | Dose bath | Dmax | 15 Gy | ||
8 | Femoral heads | Dmax | 24 Gy |
The optimization starts with optimizing on the PTV to attain sufficient PTV coverage, while respecting all constraints from the constraints list. Once an objective is optimized, it is added as an additional constraint to the constraint list and then the next objective will be optimized. The relative ranking of the objectives is based on clinical importance of the structures. A detailed description of the Erasmus‐iCycle workflow is provided in Breedveld et al., 2012.18 UrethraPlan is defined as the volume of the urethra within the PTV.